Search

Search Constraints

You searched for: Author/Creator Zilembo, Nicoletta

Search Results

1. BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study. (May 2016)

2. Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME). (December 2018)

3. Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer. (November 2019)

4. Facing the First-line in Metastatic Non-small-cell Lung Cancer – Immunotherapy and Chemotherapy. Issue 1 (2020)

5. Is there evidence for different effects among EGFR-TKIs? Systematic review and meta-analysis of EGFR tyrosine kinase inhibitors (TKIs) versus chemotherapy as first-line treatment for patients harboring EGFR mutations. Issue 2 (May 2015)

6. Lung Cancer App (LuCApp) study protocol: a randomised controlled trial to evaluate a mobile supportive care app for patients with metastatic lung cancer. Issue 2 (15th February 2019)

7. Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors. Issue 1 (27th February 2019)

8. Nausea and Vomiting during the First 3 Intercycle Periods in Chemo-naive Cancer Patients Receiving Moderately/Highly Emetogenic Therapy. Issue 6 (November 2015)

9. Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program. (May 2021)

10. Systemic Approach to Malignant Pleural Mesothelioma: What News of Chemotherapy, Targeted Agents and Immunotherapy?. Issue 1 (January 2016)